Compare Amphastar Pharmaceuticals Inc (AMPH) vs PPG Industries, Inc. (PPG) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs PPG Industries, Inc. — how do they compare? Amphastar Pharmaceuticals Inc trades at $18.72 (market cap $826.08M), while PPG Industries, Inc. trades at $116.76 (market cap $26.03B). The key difference: PPG Industries, Inc. is far larger — about 31.5× Amphastar Pharmaceuticals Inc's market cap, and PPG Industries, Inc. pays a 2.43% dividend while Amphastar Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMPH | PPG | |
|---|---|---|
Market Cap | $826.08M | $26.03B |
Sector | Health | Basic Materials |
52-Week High | $30.81 | $131.56 |
52-Week Low | $16.87 | $94.34 |
Enterprise Value | $1.22B | $32.13B |
Dividend Yield | — | 2.43% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.
The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.
PPG Industries trades at $116.76, up 0.69% today, with a bearish technical signal despite recent earnings beats. The company maintains strong profitability with a 9.83% net margin and 21.09% ROE, supported by $15.88B in 2025 revenue. Analysts show a 52.63% buy consensus with a $131.75 price target. Recent news highlights innovation in aerospace and marine coatings, though sentiment remains mixed amid modest revenue growth.
PPG offers solid fundamentals and dividend stability but faces headwinds from volume softness and margin pressure. The stock's valuation at a P/E of 16.73 appears reasonable, yet near-term catalysts are limited. Risks include economic sensitivity and competitive pressures, while institutional support and consistent cash flow provide a floor. The outlook is neutral with upside dependent on execution and market conditions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About PPG Industries, Inc.
PPG is a global producer of coatings. The company is the world's largest producer of coatings after the purchase of selected Akzo Nobel assets. PPG's products are sold to a wide variety of end users, including the automotive, aerospace, construction, and industrial markets. The company has a footprint in many regions around the globe, with less than half of sales coming from North America in recent years. PPG is focused on its coatings and specialty products and expansion into emerging regions, as exemplified by the Comex acquisition.
Read more on PPG →
